Metropolitan Life Insurance CO Intellia Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

54 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$23.82 - $32.8 $5,978 - $8,232
-251 Reduced 4.94%
4,830 $132,000
Q3 2023

Nov 14, 2023
BUY
$31.62 - $45.78 $8,316 - $12,040
263 Added 5.46%
5,081 $160,000
Q2 2023

Aug 10, 2023
BUY
$34.58 - $46.03 $11,895 - $15,834
344 Added 7.69%
4,818 $196,000
Q1 2023

May 15, 2023
SELL
$33.3 - $44.82 $25,874 - $34,825
-777 Reduced 14.8%
4,474 $166,000
Q4 2022

Jun 14, 2023
BUY
$33.21 - $62.69 $25,804 - $48,710
777 Added 17.37%
5,251 $183 Million
Q4 2022

Mar 30, 2023
BUY
$33.21 - $62.69 $23,346 - $44,071
703 Added 15.46%
5,251 $183,000
Q4 2022

Feb 15, 2023
BUY
$33.21 - $62.69 $23,346 - $44,071
703 Added 15.46%
5,251 $183,000
Q3 2022

Jun 14, 2023
BUY
$53.92 - $71.7 $3,990 - $5,305
74 Added 1.65%
4,548 $255 Million
Q2 2022

Jun 20, 2023
BUY
$38.49 - $76.21 $2,848 - $5,639
74 Added 1.65%
4,548 $235,000
Q2 2022

Mar 30, 2023
BUY
$38.49 - $76.21 $6,774 - $13,412
176 Added 4.03%
4,548 $235,000
Q2 2022

Aug 11, 2022
BUY
$38.49 - $76.21 $6,774 - $13,412
176 Added 4.03%
4,548 $235,000
Q1 2022

Jun 20, 2023
SELL
$58.27 - $118.99 $5,943 - $12,136
-102 Reduced 2.28%
4,372 $317,000
Q1 2022

Mar 30, 2023
SELL
$58.27 - $118.99 $777,205 - $1.59 Million
-13,338 Reduced 75.31%
4,372 $317,000
Q1 2022

May 12, 2022
SELL
$58.27 - $118.99 $777,205 - $1.59 Million
-13,338 Reduced 75.31%
4,372 $318,000
Q4 2021

Jun 21, 2023
BUY
$100.76 - $138.36 $1.33 Million - $1.83 Million
13,236 Added 295.84%
17,710 $2.09 Million
Q4 2021

Mar 30, 2023
SELL
$100.76 - $138.36 $37,986 - $52,161
-377 Reduced 2.08%
17,710 $2.09 Million
Q4 2021

Feb 15, 2022
SELL
$100.76 - $138.36 $37,986 - $52,161
-377 Reduced 2.08%
17,710 $2.09 Million
Q3 2021

Jun 21, 2023
BUY
$132.37 - $176.78 $1.8 Million - $2.41 Million
13,613 Added 304.27%
18,087 $2.43 Million
Q3 2021

Mar 30, 2023
BUY
$132.37 - $176.78 $85,113 - $113,669
643 Added 3.69%
18,087 $2.43 Million
Q3 2021

Nov 15, 2021
BUY
$132.37 - $176.78 $85,113 - $113,669
643 Added 3.69%
18,087 $2.43 Million
Q2 2021

Jun 21, 2023
BUY
$60.88 - $161.91 $789,613 - $2.1 Million
12,970 Added 289.9%
17,444 $2.82 Million
Q2 2021

Mar 30, 2023
BUY
$60.88 - $161.91 $164,376 - $437,157
2,700 Added 18.31%
17,444 $2.82 Million
Q2 2021

Aug 16, 2021
BUY
$60.88 - $161.91 $1.06 Million - $2.82 Million
17,429 Added 116193.33%
17,444 $2.82 Million
Q1 2021

Jun 26, 2023
BUY
$46.59 - $83.68 $478,479 - $859,393
10,270 Added 229.55%
14,744 $1.18 Billion
Q1 2021

Mar 30, 2023
BUY
$46.59 - $83.68 $34,430 - $61,839
739 Added 5.28%
14,744 $1.18 Million
Q1 2021

May 14, 2021
SELL
$46.59 - $83.68 $651,794 - $1.17 Million
-13,990 Reduced 99.89%
15 $1.18 Million
Q4 2020

Jun 22, 2023
BUY
$18.83 - $63.53 $179,468 - $605,504
9,531 Added 213.03%
14,005 $761,000
Q4 2020

Mar 30, 2023
BUY
$18.83 - $63.53 $4,406 - $14,866
234 Added 1.7%
14,005 $761,000
Q4 2020

Feb 16, 2021
BUY
$18.83 - $63.53 $4,406 - $14,866
234 Added 1.7%
14,005 $762,000
Q3 2020

Jun 26, 2023
BUY
$17.47 - $24.93 $162,418 - $231,774
9,297 Added 207.8%
13,771 $273,000
Q2 2020

Jun 26, 2023
BUY
$11.14 - $22.87 $103,568 - $212,622
9,297 Added 207.8%
13,771 $289,000
Q2 2020

Mar 30, 2023
BUY
$11.14 - $22.87 $18,202 - $37,369
1,634 Added 13.46%
13,771 $289,000
Q2 2020

Aug 14, 2020
BUY
$11.14 - $22.87 $18,202 - $37,369
1,634 Added 13.46%
13,771 $289,000
Q1 2020

Jul 12, 2023
BUY
$9.44 - $15.58 $72,338 - $119,389
7,663 Added 171.28%
12,137 $148,000
Q1 2020

Mar 30, 2023
SELL
$9.44 - $15.58 $21,759 - $35,911
-2,305 Reduced 15.96%
12,137 $148,000
Q1 2020

May 15, 2020
SELL
$9.44 - $15.58 $21,759 - $35,911
-2,305 Reduced 15.96%
12,137 $148,000
Q4 2019

Jul 12, 2023
BUY
$10.43 - $17.67 $103,966 - $176,134
9,968 Added 222.8%
14,442 $211,000
Q4 2019

Mar 30, 2023
SELL
$10.43 - $17.67 $13,016 - $22,052
-1,248 Reduced 7.95%
14,442 $211,000
Q4 2019

Feb 14, 2020
SELL
$10.43 - $17.67 $13,016 - $22,052
-1,248 Reduced 7.95%
14,442 $212,000
Q3 2019

Jul 12, 2023
BUY
$13.07 - $18.51 $146,593 - $207,608
11,216 Added 250.69%
15,690 $209,000
Q3 2019

Mar 30, 2023
BUY
$13.07 - $18.51 $59,782 - $84,664
4,574 Added 41.15%
15,690 $209,000
Q3 2019

Nov 14, 2019
BUY
$13.07 - $18.51 $59,782 - $84,664
4,574 Added 41.15%
15,690 $209,000
Q2 2019

Jul 12, 2023
BUY
$13.88 - $18.41 $92,190 - $122,279
6,642 Added 148.46%
11,116 $181,000
Q1 2019

Jul 13, 2023
BUY
$12.79 - $17.62 $84,951 - $117,032
6,642 Added 148.46%
11,116 $189,000
Q1 2019

Mar 30, 2023
BUY
$12.79 - $17.62 $75,013 - $103,341
5,865 Added 111.69%
11,116 $189,000
Q1 2019

May 16, 2019
SELL
$12.79 - $17.62 $709,640 - $977,628
-55,484 Reduced 83.31%
11,116 $189,000
Q1 2019

May 15, 2019
BUY
$12.79 - $17.62 $709,640 - $977,628
55,484 Added 499.14%
66,600 $18.8 Million
Q4 2018

Jul 13, 2023
BUY
$11.39 - $27.13 $75,652 - $180,197
6,642 Added 148.46%
11,116 $151,000
Q4 2018

Feb 14, 2019
BUY
$11.39 - $27.13 $98,887 - $235,542
8,682 Added 356.7%
11,116 $152,000
Q3 2018

Jul 13, 2023
BUY
$25.78 - $32.6 $171,230 - $216,529
6,642 Added 148.46%
11,116 $318 Million
Q3 2018

Nov 14, 2018
SELL
$25.78 - $32.6 $223,821 - $283,033
-8,682 Reduced 78.1%
2,434 $70,000
Q2 2018

Aug 15, 2018
BUY
$20.02 - $30.79 $109,389 - $168,236
5,464 Added 96.67%
11,116 $0
Q4 2017

Feb 15, 2018
SELL
$17.39 - $31.12 $93,279 - $166,927
-5,364 Reduced 48.69%
5,652 $109,000
Q2 2017

Aug 14, 2017
BUY
N/A
11,016
11,016 $176,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $926M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email